Daily Respiratory Research Analysis
Three high-impact respiratory studies stand out today: a Lancet Global Health meta-analysis quantifies the substantial prevalence of hypoxaemia across ages in LMICs and links it to a fivefold higher mortality risk; a pooled, multicountry test-negative analysis shows that 2023 Southern Hemisphere influenza vaccines halved hospitalizations; and a randomized crossover trial in Nigeria demonstrates that automated oxygen control on low-cost CPAP increases time in safe SpO2 for preterm infants.
Summary
Three high-impact respiratory studies stand out today: a Lancet Global Health meta-analysis quantifies the substantial prevalence of hypoxaemia across ages in LMICs and links it to a fivefold higher mortality risk; a pooled, multicountry test-negative analysis shows that 2023 Southern Hemisphere influenza vaccines halved hospitalizations; and a randomized crossover trial in Nigeria demonstrates that automated oxygen control on low-cost CPAP increases time in safe SpO2 for preterm infants.
Research Themes
- Global hypoxaemia burden and oxygen systems in LMICs
- Seasonal influenza vaccine effectiveness against severe disease
- Automation in neonatal respiratory support (CPAP oxygen control)
Selected Articles
1. The prevalence of hypoxaemia in paediatric and adult patients in health-care facilities in low-income and middle-income countries: a systematic review and meta-analysis.
Across 213 studies with 601,757 participants from LMICs, pooled hypoxaemia prevalence was 24.5% in neonates, 12.1% in children, and 10.8% in adults, and hypoxaemia was associated with 4.84-fold higher odds of death. Burden was highest in neonatal and respiratory conditions but remained substantial across other illnesses.
Impact: This provides robust, cross-age quantification of hypoxaemia in LMIC facilities and demonstrates its strong prognostic significance, directly informing oxygen system planning and guideline integration.
Clinical Implications: Integrate pulse oximetry screening and reliable oxygen therapy across all levels of care, prioritize neonatal and respiratory conditions, and embed hypoxaemia assessment into triage and quality-of-care metrics.
Key Findings
- Pooled hypoxaemia prevalence: neonates 24.5% (95% CI 19.9–29.4), children 12.1% (10.0–14.4), adults 10.8% (4.9–18.7).
- Hypoxaemia increased odds of death by 4.84 (95% CI 4.11–5.69).
- Highest burden in neonatal and primary respiratory conditions, but hypoxaemia was common across many other diagnoses.
Methodological Strengths
- Large-scale meta-analysis spanning 213 studies and 601,757 participants across LMICs
- Age-stratified estimates and evaluation across diagnostic categories
Limitations
- Heterogeneity across studies and settings; variable SpO2 thresholds and measurement protocols
- Geographic concentration in sub-Saharan Africa and South Asia may limit generalizability
Future Directions: Develop and evaluate scalable oxygen systems (supply, pulse oximetry, automated titration), define context-specific SpO2 thresholds, and implement quality improvement programs to reduce hypoxaemia-related mortality.
BACKGROUND: Hypoxaemia (low oxygen saturation in blood) is a key predictor of in-hospital mortality, affecting people of all ages with many different conditions. Early detection and treatment of hypoxaemia are critical, but there are few data to quantify hypoxaemia burden outside the child pneumonia population. We aimed to estimate hypoxaemia prevalence for adults and children with acute illness attending health facilities in low-income and middle-income countries (LMICs). METHODS: We conducted a s
2. Effectiveness of 2023 southern hemisphere influenza vaccines against severe influenza-associated illness: pooled estimates from eight countries using the test-negative design.
In 12,609 hospitalized SARI patients across eight countries, pooled vaccine effectiveness (VE) of 2023 Southern Hemisphere influenza vaccines against influenza-associated hospitalization was 51.9%, with substantial heterogeneity. Where data allowed, VE against ICU admission was also estimated. Benefits were observed in priority groups, including older adults and those with comorbidities.
Impact: Provides timely, multicountry VE estimates against severe outcomes using harmonized methods, directly supporting vaccination policies and risk communication across diverse settings.
Clinical Implications: Sustain and target influenza vaccination for high-risk groups; use pooled VE to inform resource allocation and ICU surge planning during influenza seasons.
Key Findings
- Pooled VE against influenza-associated hospitalization: 51.9% (95% CI 37.2–66.7) across eight countries.
- Analysis included 12,609 hospitalized SARI patients (4,388 test-positive; 8,221 test-negative).
- Network enabled VE estimation for priority groups (children, older adults, comorbidities) and, in some settings, against ICU admission.
Methodological Strengths
- Harmonized test-negative design across multiple national networks
- Large pooled sample spanning eight countries and diverse epidemiology
Limitations
- Substantial between-country heterogeneity; potential residual confounding inherent to observational designs
- Incomplete ICU VE estimates in some countries due to limited data
Future Directions: Refine age- and risk-specific VE estimates, integrate viral genomic data to assess strain mismatch effects, and evaluate programmatic strategies to improve vaccine uptake in priority populations.
BACKGROUND: Annual estimates of seasonal influenza vaccine effectiveness can guide global risk communication and vaccination strategies to mitigate influenza-associated illness. We aimed to evaluate vaccine effectiveness in countries using the 2023 southern hemisphere influenza vaccine formulation. METHODS: We evaluated end-of-season influenza vaccine effectiveness across eight countries (Argentina, Australia, Brazil, Chile, New Zealand, Paraguay, Thailand, and Uruguay) that used the 2023 southern h
3. Automated oxygen control for preterm infants receiving continuous positive airway pressure in southwest Nigeria: an open-label, randomised, crossover trial.
Among 49 randomized preterm infants on CPAP (80 study periods analyzed from 46 infants), automated oxygen titration increased the proportion of time spent in the prespecified safe SpO2 range versus manual control. The intervention paired a proven control algorithm with a low-cost CPAP device in a LMIC setting.
Impact: Demonstrates pragmatic feasibility and physiological benefit of automated oxygen control in preterm infants in resource-limited settings, with potential to standardize safer oxygen delivery and reduce hypo/hyperoxaemia.
Clinical Implications: Consider adopting automated oxygen control in neonatal CPAP units to increase time-in-target SpO2, alongside staff training and monitoring to ensure safety and integration with existing workflows.
Key Findings
- Open-label randomized crossover trial in two Nigerian hospitals enrolled 49 preterm infants; 80 periods from 46 infants contributed to the primary analysis.
- Automated oxygen control increased the proportion of time within the safe SpO2 target range compared with manual titration.
- Feasibility shown using a control algorithm paired with a low-cost CPAP device in a LMIC context.
Methodological Strengths
- Randomized crossover design reduces between-subject variability
- Real-world implementation in LMIC hospitals with low-cost equipment
Limitations
- Open-label design and modest sample size limit precision and potential bias
- Short intervention windows (two 24-h periods) preclude clinical outcome assessment
Future Directions: Conduct larger multicenter trials to assess clinical outcomes (hypo-/hyperoxaemia events, retinopathy of prematurity, mortality), cost-effectiveness, and implementation strategies at scale.
BACKGROUND: Titration of oxygen therapy to target safe oxygen saturation (SpO METHODS: In this open-label, randomised, crossover trial, preterm infants with a gestational age younger than 34 weeks (or a birthweight <2 kg if gestation was unknown) who were aged 12 h or older and required CPAP and oxygen were recruited at two hospitals in southwest Nigeria. Participants were randomly assigned (1:1) to one of two intervention sequences (ie, to commence the study on automated oxygen control or manual